Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04586400
Other study ID # 201706062
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 27, 2017
Est. completion date June 2026

Study information

Verified date May 2023
Source Washington University School of Medicine
Contact F. S. Cole, M.D.
Phone 314-454-6183
Email fcole@wustl.edu
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Patients with deletion of chromosome 9 P are rare (~200 in the medical literature) and have a diverse set of phenotypic characteristics. We propose using state of the art genome sequencing methods to define the location and size of the deleted portion of chromosome 9 P as well as the genetic background in affected patients (whole genome sequencing) and correlate the genes in the deleted portion of chromosome 9 P with specific phenotypic characteristics of each patient. Enrolled participants will be asked to complete a detailed questionnaire, complete a medical release form, and provide a biospecimen sample.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date June 2026
Est. primary completion date June 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Having 9P minus syndrome/ deletions on the 9th chromosome - Parents and siblings of affected individuals may also be included to determine contribution of genetic background to phenotypic characteristics Exclusion Criteria: - No exclusion criteria for either affected individuals or their parents or siblings.

Study Design


Locations

Country Name City State
United States Washington University School of Medicine Saint Louis Missouri

Sponsors (5)

Lead Sponsor Collaborator
Washington University School of Medicine Dickson, Patricia I., M.D., Milbrandt, Jeffrey, MD, PhD, Mitra, Rob, PhD, Turner, Tychele, PhD

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Genotypic and Phenotypic Correlation By use of demographic and genetic material we hope to gain a better understanding between the deletion on the short arm of the 9th chromosome and the features presented. As enrollment increases the team hopes to have preliminary results by 2022